Form 4 for KRSA Korsana Biosciences, Inc.
Accepted 2025-03-27 00:00:00 ET · period of report 2025-03-25 · accession 0000950170-25-046099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-27 | 2025-03-25 | KRSA | Higgins Michael J | Dir | A - Grant | $2.75 | +9,090 | 30.7K | +42% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-25 | A | A | 9,090 | $2.75 | 30,740 | D | — | — | (F1) On March 25, 2025, the reporting person purchased directly from the Issuer 9,090 shares of Common Stock for a total purchase price of approximately $25,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein. |